approached significanceP = 0.052
Evidence of a difference in seroprevalence for SFGR between males and females approached significance (males 44% ( n = 39), females 19% ( n = 23); P = 0.052).
Evidence of a difference in seroprevalence for SFGR between males and females approached significance (males 44% ( n = 39), females 19% ( n = 23); P = 0.052).